Myriam Hill received a B.Sc. degree in Chemistry from the National University of Colombia and a M.Sc. in Chemistry from the Weizmann Institute of Science in Israel. Ms. Hill is the manager of the Nanotechnology Section at the New Substances Assessment and Control Bureau at Health Canada, where she currently oversees the regulatory assessment of human health risks associated with the use of engineered nanomaterials. Ms. Hill has over 20 years experience in the risk assessment and risk management of industrial chemicals, and has served as Health Canada’s representative on a number of national and international nanotechnology committees including the Canada-US Regulatory Cooperation Council – (RCC) Nanotechnology initiative and the OECD Working Party on Manufactured Nanomaterials.